DISBROW JARRETT (Chief Operating Officer) received a stock award from AYTU BIOPHARMA, INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 10/7/2025ACC: 0001437749-25-030648
Officer· Chief Operating Officer
Since Oct 2018
+32.11K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
32.11K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+19.61K
Price / share
—
Trade value
—
% of position
66.5%
10/3/2025
29.46K→49.07K
Common Stock
Direct
Shares
+12.50K
Price / share
—
Trade value
—
% of position
25.5%
10/3/2025
49.07K→61.57K
Total
Net shares
+32.11K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/3/2025 | A · Award | +19.61K | — | — | 66.5% | 29.46K | 49.07K |
| Common Stock Direct | 10/3/2025 | A · Award | +12.50K | — | — | 25.5% | 49.07K | 61.57K |
| Total | +32.11K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported